¼¼°èÀÇ °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ½ÃÀå
Pneumatic Nebulizers
»óǰÄÚµå : 1542811
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 9¾ï 6,260¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 7¾ï 3,210¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 9¾ï 6,260¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â°£ 4.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Breath-Actuated °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú´Â CAGR 3.6%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 3¾ï 8,200¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È£Èí Ȱ¼º °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ¾à 1¾ï 9,100¸¸ ´Þ·¯, Áß±¹Àº CAGR 6.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¹Ì±¹ÀÇ °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ½ÃÀåÀº 2023³â 1¾ï 9,100¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 6.7%ÀÇ ¼ºÀå·üÀ» º¸À̸ç 2030³â¿¡´Â 2¾ï 1,780¸¸ ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 1.2%¿Í 3.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ 2.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

È£Èí±â °ü¸®¿¡¼­ °­È­µÈ °ø±â¾Ð½Ä ³×ºí¶óÀÌÀúÀÇ ¿ªÇÒ

Á¦Æ® ºÐ¹«±â·Îµµ ¾Ë·ÁÁø °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú´Â ¾à¹°À» ¹Ì¼¼ÇÑ ¹Ì¸³ÀÚ·Î ¸¸µé¾î Æó¿¡ Á÷Á¢ ÁÖÀÔÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â ¾ÐÃà °ø±â ¶Ç´Â »ê¼Ò¸¦ »ç¿ëÇÏ¿© ¾×ü ¾à¹°À» ¿¡¾î·ÎÁ¹·Î º¯È¯ÇÏ¿© ƯÈ÷ È£Èí±â ÁúȯÀ» ¾Î°í Àִ ȯÀÚ°¡ ¾à¹°À» Æó ±í¼÷ÀÌ ÈíÀÔÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ºÐ¹«±â´Â ¾ÐÃà±â, ¾à¾× ÄÅ, ¸¶¿ì½ºÇǽº ¶Ç´Â ¸¶½ºÅ©·Î ±¸¼ºµË´Ï´Ù. ÀåÄ¡°¡ ÀÛµ¿ÇÏ¸é ¾ÐÃà±â°¡ ÄÅ¿¡ ´ã±ä ¾×ü ¾àǰ¿¡ °ø±â¸¦ ºÒ¾î³Ö¾î ¹Ì¸³ÀÚ·Î ¸¸µé¾î ȯÀÚ°¡ ÈíÀÔÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ ¹æ¹ýÀº õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ³¶Æ÷¼º ¼¶À¯Áõ µîÀÇ Ä¡·á¿¡ »ç¿ëµÇ´Â ±â°üÁö È®ÀåÁ¦, ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀÌµå ¹× ±âŸ ¾à¹°À» Åõ¿©ÇÏ´Â µ¥ ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. È£Èí±â¿¡ Á÷Á¢ ¾à¹°À» Åõ¿©ÇÒ ¼ö Àֱ⠶§¹®¿¡ °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú´Â È£Èí±â Ä¡·á¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù.

°ø±â ºÐ¹«±â´Â ÀÇ·á ÇöÀå¿¡¼­ ¾î¶»°Ô Ȱ¿ëµÇ°í ÀÖ³ª¿ä?

°ø±â ºÐ¹«±â´Â ±Þ¼º ¹× ¸¸¼º È£Èí±â Áúȯ Ä¡·á¿¡ È¿°úÀûÀ̱⠶§¹®¿¡ ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÀ±Þ ÀÇ·á ÇöÀå¿¡¼­ ÀÌ ºÐ¹«±â´Â ±â°üÁö È®ÀåÁ¦¸¦ ½Å¼ÓÇÏ°Ô Åõ¿©ÇÏ¿© ÁßÁõ õ½Ä ¹ßÀÛÀ̳ª COPD ¾ÇÈ­¸¦ °æÇèÇÑ È¯Àڵ鿡°Ô Áï°¢ÀûÀÎ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á¿¡¼­´Â Áõ»óÀ» °ü¸®Çϰí Àç¹ßÀ» ¿¹¹æÇϱâ À§ÇØ Á¤±âÀûÀÎ À¯Áö ¾à¹°À» Åõ¿©ÇØ¾ß ÇÏ´Â ¸¸¼º È£Èí±â Áúȯ ȯÀڵ鿡°Ô ÀÚÁÖ »ç¿ëµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð¿¡¼­´Â È£Èí±â ÁúȯÀÇ ±Þ¼º±â Ä¡·á¿Í ÀÏ»óÀûÀÎ °ü¸® ¸ðµÎ¿¡ °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú°¡ »ç¿ëµÇ¸ç, Á¾Á¾ Á¾ÇÕÀûÀΠȣÈí±â Ä¡·á ÇÁ·Î±×·¥ÀÇ ÀϺηΠ»ç¿ëµË´Ï´Ù. ¶ÇÇÑ, ¼Ò¾Æ°ú¿¡¼­´Â ÈíÀԱ⸦ Àß »ç¿ëÇÏÁö ¸øÇÏ´Â ¾î¸°À̵鵵 ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â ºÐ¹«±â¸¦ ÀÚÁÖ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. °ø±â¾Ð½Ä ³×ºí¶óÀÌÀúÀÇ ´ÙÀç´Ù´ÉÇÔ°ú ½Å·Ú¼ºÀº ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ È¿°úÀûÀΠȣÈí±â Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

°ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ±â¼úÀÇ ÇöÀç µ¿ÇâÀº?

°ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ±â¼ú ºÐ¾ß´Â È¿À²¼º, È޴뼺 ¹× ȯÀÚ ÆíÀǼºÀ» ³ôÀ̱â À§ÇÑ ¸î °¡Áö Áß¿äÇÑ Æ®·»µå¿Í ÇÔ²² ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ Æ®·»µå Áß Çϳª´Â ´õ ÀÛ°í ÈÞ´ë °¡´ÉÇÑ ºÐ¹«±â ÀåÄ¡ÀÇ °³¹ß·Î, ƯÈ÷ Ä¡·á°¡ ÀÚÁÖ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ´õ ³ôÀº À̵¿¼º°ú ÆíÀǼºÀ» Á¦°øÇÕ´Ï´Ù. ¼ÒÀ½ °¨¼Ò ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ÀåÄ¡´Â ´õ Á¶¿ëÇØÁö°í, ƯÈ÷ ¼Ò¾Æ ¹× ³ëÀΠȯÀÚÀÇ »ç¿ë ÆíÀǼºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ä¡·á ¼øÀÀµµ ¸ð´ÏÅ͸µ ¹× Åõ¾à·® ±â·ÏÀ» À§ÇÑ ¸ð¹ÙÀÏ ¾Û ¿¬°á°ú °°Àº µðÁöÅÐ °Ç°­ ±â´ÉÀ» ÅëÇÕÇÑ ½º¸¶Æ® ºÐ¹«±â¿¡ ´ëÇÑ °ü½Éµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¾ÐÃà±â ±â¼úÀÇ ¹ßÀüÀ¸·Î ¾à¹° Àü´ÞÀÇ È¿À²¼ºÀÌ Çâ»óµÇ¾î ´õ ¸¹Àº ¾çÀÇ ¾à¹°ÀÌ Æó¿¡ µµ´ÞÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ȯÀÚÀÇ Ä¡·á °á°ú¿Í Ä¡·á ¿ä¹ý ¼øÀÀµµ¸¦ °³¼±Çϱâ À§ÇÑ ºÐ¹«±â ±â¼úÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀ» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

°ø±â ºÐ¹«±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

°ø±â ºÐ¹«±â ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÇ Çʿ伺À» ¹Ý¿µÇÏ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. õ½Ä ¹× COPDÀÇ À¯º´·ü Áõ°¡´Â ȯ°æÀû ¿äÀΰú Àα¸ °í·ÉÈ­µµ ÇѸòÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ºÐ¹«±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ºÐ¹«±âÀÇ µðÀÚÀΰú ±â´ÉÀÇ ±â¼úÀû ¹ßÀüÀº ºÐ¹«±âÀÇ ¸Å·Â°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃÄÑ È¯ÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü »çÀÌ¿¡¼­ ´õ Æø³ÐÀº äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á Áõ°¡¿Í ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î ±â±â Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ¸é¼­ ºÐ¹«±â Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â º¸´Ù ±¤¹üÀ§ÇÑ ½ÃÀå ħÅõ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ±â¼úÀÇ ÅëÇÕÀº ´õ ³ªÀº Áúº´ °ü¸®¿Í Ä¡·á ¼øÀÀµµ¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î °ø±â¾Ð½Ä ³×ºí¶óÀÌÀú ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀåÀ» º¸ÀåÇϰí Çö´ë È£Èí±â Ä¡·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 41°³)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pneumatic Nebulizers Market to Reach US$962.6 Million by 2030

The global market for Pneumatic Nebulizers estimated at US$732.1 Million in the year 2023, is expected to reach US$962.6 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. Vented Pneumatic Nebulizers, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$382.0 Million by the end of the analysis period. Growth in the Breath-Actuated Pneumatic Nebulizers segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$191.0 Million While China is Forecast to Grow at 6.7% CAGR

The Pneumatic Nebulizers market in the U.S. is estimated at US$191.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$217.8 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Pneumatic Nebulizers  Market - Key Trends and Drivers Summarized

Enhancing Respiratory Care: The Role of Pneumatic Nebulizers

Pneumatic nebulizers, also known as jet nebulizers, are medical devices used to deliver medication directly into the lungs in the form of a fine mist. These devices utilize compressed air or oxygen to convert liquid medication into an aerosol, making it easier for patients, particularly those with respiratory conditions, to inhale the medication deeply into their lungs. The nebulizer consists of a compressor, a medication cup, and a mouthpiece or mask. When the device is activated, the compressor forces air through the liquid medication in the cup, creating a mist that the patient inhales. This method is particularly effective for administering bronchodilators, corticosteroids, and other medications used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The ability to deliver medication directly to the respiratory tract makes pneumatic nebulizers an essential tool in respiratory therapy.

How Are Pneumatic Nebulizers Utilized in Different Medical Scenarios?

Pneumatic nebulizers are widely used in various medical scenarios due to their effectiveness in treating acute and chronic respiratory conditions. In emergency care settings, these nebulizers provide rapid relief for patients experiencing severe asthma attacks or COPD exacerbations by delivering fast-acting bronchodilators. In home healthcare, they are commonly used by patients with chronic respiratory diseases who require regular administration of maintenance medications to manage their symptoms and prevent flare-ups. Hospitals and clinics use pneumatic nebulizers for both acute treatment and routine management of respiratory conditions, often as part of comprehensive respiratory therapy programs. Additionally, pediatric care frequently incorporates nebulizers, as they are easier to use for children who may struggle with inhalers. The versatility and reliability of pneumatic nebulizers make them indispensable in providing effective respiratory care across various healthcare environments.

What Are the Current Trends in Pneumatic Nebulizer Technology?

The field of pneumatic nebulizer technology is evolving with several key trends aimed at enhancing efficiency, portability, and patient comfort. One significant trend is the development of more compact and portable nebulizer units, which allow patients greater mobility and convenience, particularly for those who require frequent treatments. Advances in noise reduction technology are making these devices quieter, improving the user experience, especially for pediatric and elderly patients. There is also a growing focus on smart nebulizers that incorporate digital health features, such as connectivity to mobile apps for monitoring treatment adherence and logging medication usage. Improvements in compressor technology are enhancing the efficiency of drug delivery, ensuring that a higher proportion of the medication reaches the lungs. These trends reflect the ongoing innovation in nebulizer technology, aimed at improving patient outcomes and adherence to treatment regimens.

What Factors Are Driving the Growth in the Pneumatic Nebulizers Market?

The growth in the pneumatic nebulizers market is driven by several factors, reflecting the increasing prevalence of respiratory diseases and the need for effective treatment solutions. The rising incidence of asthma and COPD, partly due to environmental factors and aging populations, is a significant driver of demand for nebulizers. Technological advancements in nebulizer design and function are enhancing their appeal and usability, encouraging wider adoption among patients and healthcare providers. The growing trend towards home healthcare and the increasing availability of portable, user-friendly devices are also boosting market growth. Additionally, healthcare infrastructure improvements in emerging economies are expanding access to nebulizer therapy, supporting broader market penetration. The integration of digital health technologies is further driving growth by enabling better disease management and treatment adherence. These factors collectively ensure robust growth in the pneumatic nebulizers market, highlighting their critical role in modern respiratory care.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â